- CSF A beta 42 < 192 (+- 10%) pg/ml ( given an intra-subject laboratory variability ~ 10%).
 - Significant neuroimaging abnormalities, previously known or discovered on the initial MRI scan, including evidence of infection, infarction (> 3 mm in size ), brain tumors ( other than small meningiomas or other benign lesions ) or other focal lesions, multiple lacunes or lacunes in a critical memory structure or severe confluent microvascular disease ( but not mild white matter changes, which are frequent with aging ).
 - co-medication with NSAIDs ( longterm medication ) ( ASS is not an exclusion criteria ), Gingko- or other natural extracts, other anti-dementiva except of Donepezil.